Spinal IDH-wildtype glioma: a single center experience of rare disease

Spinal IDH-wildtype glioma: a single center experience of rare disease

Saved in:

Bibliographic Details
Main Authors:	H. Gull, O. Gembruch, L. Rauschenbach, P. Ketelauri, R. Jabbarli, M. Darkwah Oppong, Y. Ahmadipour, U. Sure, N. Özkan
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Brain and Spine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772529424013614
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk factors for anterior plating failure after anterior cervical corpectomy and fusion
by: A. Togyzbayeva, et al.
Published: (2024-01-01)

Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated
by: Malcolm F. McDonald, et al.
Published: (2025-01-01)

Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy
by: Shigeo Ohba, et al.
Published: (2025-01-01)

Acute Coronary Syndrome After Aneurysmal Subarachnoid Hemorrhage: Incidence, Risk Factors and Impact on the Outcome
by: Džiugas Meška, et al.
Published: (2024-11-01)

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
by: Kristian A. Choate, et al.
Published: (2024-10-01)

IDH-mutant gliomas in children and adolescents - from biology to clinical trials
by: Louise Evans, et al.
Published: (2025-01-01)

IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH‐mutant astrocytoma PMMRDIA: a systematic review
by: Olfat Ahmad, et al.
Published: (2024-12-01)

Detection of IDH mutation in glioma by desorption electrospray ionization (DESI) tandem mass spectrometry
by: Mahdiyeh Shahi, et al.
Published: (2024-11-01)

IDH-mutant glioma risk stratification via whole slide images: Identifying pathological feature associations
by: Xiaotao Wang, et al.
Published: (2025-01-01)

The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01)

Multidisciplinary quantitative and qualitative assessment of IDH-mutant gliomas with full diagnostic deep learning image reconstruction
by: Christer Ruff, et al.
Published: (2024-12-01)

Gliomas Difusos do Adulto: Prevalência da Mutação IDH1 em um Hospital Universitário
by: Vitor Bonk Rizzo, et al.
Published: (2025-01-01)

Association of IDH1 Mutation Detected in Circulating-free DNA With Survival Outcome in Patients Affected by Glioma
by: M. Ruglioni, et al.
Published: (2023-11-01)

VASARI 2.0: a new updated MRI VASARI lexicon to predict grading and IDH status in brain glioma
by: Alberto Negro, et al.
Published: (2024-12-01)

Association of IDH1 Mutation and MGMT Promoter Methylation with Clinicopathological Parameters in an Ethnically Diverse Population of Adults with Gliomas in England
by: Hiba A. Wanis, et al.
Published: (2024-11-01)

Radiomic study on preoperative multi‐modal magnetic resonance images identifies IDH‐mutant TERT promoter‐mutant gliomas
by: Haoyu Wang, et al.
Published: (2023-02-01)

Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
by: Xinli Zhang, et al.
Published: (2024-12-01)

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy
by: Mariam Ben Kacem, et al.
Published: (2024-12-01)

The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A C-MET PET Study
by: Nijiati Kudulaiti MD, et al.
Published: (2019-12-01)

Epigenetic and clinical characterization of adult diffusely infiltrating intramedullary spinal cord gliomas
by: M. Bschorer, et al.
Published: (2024-01-01)

Weakly supervised deep learning-based classification for histopathology of gliomas: a single center experience
by: Mingrong Zuo, et al.
Published: (2025-01-01)

Efficacy and safety of IDH inhibitors in IDH-mutated cancers: a systematic review and meta-analysis of 4 randomized controlled trials
by: Zelin Cai, et al.
Published: (2024-11-01)

Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging
by: Xingrui Wang, et al.
Published: (2025-02-01)

Exploration of different quantitative polymerase chain reaction-based genotyping methods to distinguish Apcmin/+ mice from wildtype mice.
by: Yuting Sun, et al.
Published: (2025-01-01)

Analysis of the postoperative sagittal alignment after surgical therapy of spinal metastasis: A single center study
by: C.M. Schmitt, et al.
Published: (2024-01-01)

IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
by: Alexander Bray, et al.
Published: (2025-01-01)

Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
by: Anne Clavreul, et al.
Published: (2024-11-01)

Single-center experience and evaluation of rare ıntracranial abscesses in childhood
by: Nihal Yildiz, et al.
Published: (2025-02-01)

BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01)

Patients' Characteristics Associated With Size of Ruptured and Unruptured Intracranial Aneurysms
by: Thiemo Florin Dinger, et al.
Published: (2024-11-01)

Quantitative Measurement of the Kinase Activity of Wildtype ALPK1 and Disease-Causing ALPK1 Mutants Using Cell-Free Radiometric Phosphorylation Assays
by: Tom Snelling
Published: (2024-11-01)

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma
by: Marshall Pitz, et al.
Published: (2025-02-01)

Optic nerve glioma
by: U. Masilionytė, et al.
Published: (2023-10-01)

Analysis of postoperative sagittal alignment changes after resection of primary extradural spinal tumors and stabilization: A single center retrospective study
by: P. Warnke, et al.
Published: (2024-01-01)

Single- and Multilevel Corpectomy and Vertebral body replacement for treatment of spinal infections. A retrospective single-center study of 100 cases
by: J. Neuhoff, et al.
Published: (2024-01-01)

Valproic acid targets IDH1 mutants through alteration of lipid metabolism
by: Lubayna S. Elahi, et al.
Published: (2024-08-01)

Effect of Electronic Moxibustion in Patients with IDH: A Randomized Crossover Pilot Study
by: Liu TJ, et al.
Published: (2024-12-01)

Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory
by: Emmanuel Mandonnet, et al.
Published: (2024-11-01)

Primary Dural Spinal Lymphoma Presentation of a Rare Spinal Tumor Case
by: Dilber Ayçiçek Çeçen, et al.
Published: (2015-01-01)

Measurement of the Activity of Wildtype and Disease-Causing ALPK1 Mutants in Transfected Cells With a 96-Well Format NF-κB/AP-1 Reporter Assay
by: Tom Snelling
Published: (2024-11-01)